Assistant Professor
McGill University
Health Services Research
Implementation Science; Knowledge Translation; Clinical Epidemiology

Assistant Professor, McGill University
Visiting Fellow, Kirby Institute, UNSW Sydney

680 Sherbrooke West, 18th Floor, Office 1812
Montreal Quebec H3A 2M7

Dr. Guillaume Fontaine, PhD, RN, serves as an Assistant Professor of Implementation Science at McGill University and holds a Visiting Fellow position at the Kirby Institute, University of New South Wales in Sydney, Australia. He earned his PhD from the University of Montreal and subsequently completed a Postdoctoral Fellowship in Clinical Epidemiology at the Centre for Implementation Research of the Ottawa Hospital Research Institute, University of Ottawa. He was a CanHepC Postdoctoral Fellow and has been honored with several of Canada's most prestigious graduate and postdoctoral awards, including the CIHR Vanier Scholarship (2018), the CIHR Banting Postdoctoral Fellowship (2021), and the Governor General of Canada Academic Gold Medal (2022).

As an implementation scientist, Dr. Fontaine navigates the complex terrain of bringing scientific advancements into everyday use, devising strategies to overcome barriers and ensure that research findings effectively enhance healthcare and societal outcomes. His expertise lies in the methodological approaches used throughout implementation research to support adoption, penetration and sustainability of evidence-based interventions, practices, programs and policies in healthcare.

His research program is dedicated to advancing implementation research with a focus on infectious diseases, notably hepatitis C. Central to his work is a profound exploration of implementation strategies, exemplified by his systematic reviews on the implementation of decentralized point-of-care testing for HIV, viral hepatitis, and STIs. He also investigates the interplay between health equity and implementation, examining how societal factors impact health systems. Collaborating closely with community organizations, he uses innovative approaches from implementation science to refine hepatitis C diagnostic processes and amplify community engagement.